Berberine

What it is

Berberine is a bitter, bright-yellow isoquinoline alkaloid extracted from plants such as European barberry (Berberis vulgaris), goldenseal (Hydrastis canadensis), and Chinese goldthread (Coptis chinensis) [1] [2]. It has a long history of traditional use in Ayurvedic and Chinese herbal medicine for digestive infections and metabolic conditions [3]. In dietary supplements, it is most commonly sold as berberine hydrochloride in capsules ranging from 400 mg to 500 mg [1].

How it might work

Laboratory and clinical studies propose that berberine works through several distinct metabolic pathways [4]. It activates AMP-activated protein kinase (AMPK), a central cellular energy sensor that promotes glucose uptake into cells and limits glucose production in the liver [1]. Human trials also show that berberine upregulates insulin receptor expression in peripheral tissues, which improves insulin sensitivity [4]. In the gut, berberine influences the intestinal microbiome and delays carbohydrate absorption [3].

What the research says

Clinical research shows that berberine consistently improves blood sugar markers in people with type 2 diabetes [5] [3]. In head-to-head pilot trials, 500 mg taken three times daily lowered HbA1c by 2.0% (from 9.5% to 7.5%) and fasting blood glucose by 3.7 mmol/L, matching the efficacy of metformin [1]. A 2019 meta-analysis of 28 trials involving 2,313 participants reported average reductions in fasting glucose of 0.54 mmol/L and in HbA1c of 0.54% [5]. A 2021 meta-analysis of 46 trials confirmed these glycemic improvements and noted concurrent decreases in total cholesterol, LDL, and triglycerides [3].

For weight and body composition, pooled data demonstrate modest but consistent reductions [6]. A 2026 meta-analysis of 23 trials found that berberine reduced body weight by an average of 0.88 kg and body mass index by 0.48 points [6]. An earlier 2020 review of 12 trials reported an average weight drop of 2.07 kg and a waist circumference reduction of 1.08 cm [7].

Doses used in studies

Human trials generally administer 900 mg to 1,500 mg of berberine daily, almost always divided into two or three 500 mg doses taken just before or with meals [1] [5]. Study durations usually span 8 to 12 weeks [1] [7]. Daily doses exceeding 2,000 mg have not shown added glycemic effectiveness in meta-analyses and lead to more frequent stomach irritation [5].

Safety and interactions

Berberine has several important safety concerns and drug interactions [2].

• Common side effects: Gastrointestinal symptoms are common, occurring in about 34.5% of trial participants [1]. These include constipation, diarrhea, abdominal cramps, nausea, and bloating [1].
• Upper limits and toxicity: No official dietary tolerable upper intake level has been established by health authorities [2]. Doses up to 1,500 mg daily have been used in 12-week trials without liver or kidney toxicity, but long-term high-dose safety remains unstudied [1].
• Drug interactions: Berberine strongly inhibits cytochrome P450 enzymes, particularly CYP3A4 and CYP2D6 [2]. This can substantially increase blood levels of medications metabolized by these enzymes, such as statins, calcium channel blockers, immunosuppressants, and anticoagulants [2]. It also alters the absorption of metformin by competing for intestinal transporters [8]. Combining berberine with prescription diabetes drugs can increase the risk of hypoglycemia [5].
• Pregnancy and breastfeeding: Berberine is contraindicated during pregnancy and breastfeeding [2]. It crosses the placenta and enters breast milk, where it can displace bilirubin from albumin and cause kernicterus in newborns, as well as stimulate uterine contractions [2].
• Underlying health conditions: Individuals with liver disease, kidney impairment, or those taking multiple prescription medications should avoid berberine unless advised by their doctor [2].

Caveats and open questions

Most published trials on berberine are small, short (under 12 weeks), and carried out with variable reporting of blinding and randomisation methods [5] [6]. Unlike standard pharmaceutical therapies, berberine has not been evaluated in large-scale, long-term cardiovascular outcome trials to assess its impact on heart attacks, strokes, or diabetic complications [1] [5]. Supplement purity and actual berberine alkaloid content also vary significantly across commercial brands [6].